1076352
Bretylium tosylate
United States Pharmacopeia (USP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 61-75-6
Synonym(S): (o-Bromobenzyl)ethyldimethylammonium p-toluenesulfonate
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 200 MG | 1076352-200-MG | In Stock | ₹ 45,032.00 |
1076352 - 200 MG
In Stock
Quantity
1
Base Price: ₹ 45,032.00
GST (18%): ₹ 8,105.76
Total Price: ₹ 53,137.76
grade
pharmaceutical primary standard
API family
bretylium
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
Cc1ccc(cc1)S([O-])(=O)=O.CC[N+](C)(C)Cc2ccccc2Br
InChI
1S/C11H17BrN.C7H8O3S/c1-4-13(2,3)9-10-7-5-6-8-11(10)12;1-6-2-4-7(5-3-6)11(8,9)10/h5-8H,4,9H2,1-3H3;2-5H,1H3,(H,8,9,10)/q+1;/p-1
InChI key
KVWNWTZZBKCOPM-UHFFFAOYSA-M
Gene Information
human ... SLC6A2(6530)
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Medchemexpress LLC HY-12961A 5mg Medchemexpress, Bretylium (tosylate) CAS:61-75-6 Purity:>98% | Medchemexpress LLC | ₹ 6,468.34 | |
 | eMolecules N-(2-Bromobenzyl)-N,N-dimethylethanaminium 4-methylbenzenesulfonate | 61-75-6 | MFCD00038731 | 250mg | eMolecules | ₹ 46,407.74 | |
 | Sigma Aldrich Fine Chemicals Biosciences Bretylium tosylate | 61-75-6 | MFCD00038731 | 200MG | Sigma Aldrich Fine Chemicals Biosciences | ₹ 50,719.97 | |
 | 61-75-6 | Bretylium tosylate | A2B Chem | ₹ 1,796.76 - ₹ 25,668.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Bretylium tosylate USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.Also, for use with USP monographs such as:Bretylium Tosylate InjectionBretylium Tosylate in Dextrose Injection
- Biochem/physiol Actions: Bretylium tosylate has a biphasic response, initially inducing norepinephrine release followed by sympathetic ganglionic blockade; class III antiarrhythmic agent; competitive inhibitor of acetylcholinesterase.
- Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
P261 - P264 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
grade: pharmaceutical primary standard
API family: bretylium
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
SMILES string: Cc1ccc(cc1)S([O-])(=O)=O.CC[N+](C)(C)Cc2ccccc2Br
InChI: 1S/C11H17BrN.C7H8O3S/c1-4-13(2,3)9-10-7-5-6-8-11(10)12;1-6-2-4-7(5-3-6)11(8,9)10/h5-8H,4,9H2,1-3H3;2-5H,1H3,(H,8,9,10)/q+1;/p-1
InChI key: KVWNWTZZBKCOPM-UHFFFAOYSA-M
Gene Information: human ... SLC6A2(6530)
grade:
pharmaceutical primary standard
API family:
bretylium
manufacturer/tradename:
USP
application(s):
pharmaceutical (small molecule)
format:
neat
SMILES string:
Cc1ccc(cc1)S([O-])(=O)=O.CC[N+](C)(C)Cc2ccccc2Br
InChI:
1S/C11H17BrN.C7H8O3S/c1-4-13(2,3)9-10-7-5-6-8-11(10)12;1-6-2-4-7(5-3-6)11(8,9)10/h5-8H,4,9H2,1-3H3;2-5H,1H3,(H,8,9,10)/q+1;/p-1
InChI key:
KVWNWTZZBKCOPM-UHFFFAOYSA-M
Gene Information:
human ... SLC6A2(6530)
grade: pharmaceutical primary standard
API family: brinzolamide
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
SMILES string: CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(cc12)S(N)(=O)=O
InChI: 1S/C12H21N3O5S3/c1-3-14-10-8-15(5-4-6-20-2)23(18,19)12-9(10)7-11(21-12)22(13,16)17/h7,10,14H,3-6,8H2,1-2H3,(H2,13,16,17)/t10-/m0/s1
InChI key: HCRKCZRJWPKOAR-JTQLQIEISA-N
Gene Information: human ... CA2(760)
grade:
pharmaceutical primary standard
API family:
brinzolamide
manufacturer/tradename:
USP
application(s):
pharmaceutical (small molecule)
format:
neat
SMILES string:
CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(cc12)S(N)(=O)=O
InChI:
1S/C12H21N3O5S3/c1-3-14-10-8-15(5-4-6-20-2)23(18,19)12-9(10)7-11(21-12)22(13,16)17/h7,10,14H,3-6,8H2,1-2H3,(H2,13,16,17)/t10-/m0/s1
InChI key:
HCRKCZRJWPKOAR-JTQLQIEISA-N
Gene Information:
human ... CA2(760)
grade: pharmaceutical primary standard
API family: brimonidine
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
SMILES string: __
InChI: 1S/C11H10BrN5.C4H6O6/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8;5-1(3(7)8)2(6)4(9)10/h1-4H,5-6H2,(H2,15,16,17);1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1
InChI key: QZHBYNSSDLTCRG-LREBCSMRSA-N
Gene Information: __
grade:
pharmaceutical primary standard
API family:
brimonidine
manufacturer/tradename:
USP
application(s):
pharmaceutical (small molecule)
format:
neat
SMILES string:
__
InChI:
1S/C11H10BrN5.C4H6O6/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8;5-1(3(7)8)2(6)4(9)10/h1-4H,5-6H2,(H2,15,16,17);1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1
InChI key:
QZHBYNSSDLTCRG-LREBCSMRSA-N
Gene Information:
__
grade: pharmaceutical primary standard
API family: __
manufacturer/tradename: USP
application(s): (Pharmaceutical small molecule)
format: neat
SMILES string: __
InChI: 1S/C8H6BrN3/c9-7-5(10)1-2-6-8(7)12-4-3-11-6/h1-4H,10H2
InChI key: IRAOSCSPAYZRJE-UHFFFAOYSA-N
Gene Information: __
grade:
pharmaceutical primary standard
API family:
__
manufacturer/tradename:
USP
application(s):
(Pharmaceutical small molecule)
format:
neat
SMILES string:
__
InChI:
1S/C8H6BrN3/c9-7-5(10)1-2-6-8(7)12-4-3-11-6/h1-4H,10H2
InChI key:
IRAOSCSPAYZRJE-UHFFFAOYSA-N
Gene Information:
__